H
Harvest
Tax-loss replacement research
ARWR
Arrowhead Pharmaceuticals
Health CareBiotechnologyBiotechnology
28 stocks · 12 ETFs
data as of Aug 24, 2026
REPLACEMENT RESEARCH

Tax-loss harvesting alternatives for ARWR

Among the 28 Biotechnology peers screened, CYTK (Cytokinetics) has tracked ARWR most closely over the past year, with a return correlation of 0.38. The strongest fund stand-in is XBI (SPDR S&P Biotech ETF) at 0.48 over the past year. Correlations are computed from daily closing-price returns aligned by trading day.

Run this search live in the Screener →
STOCKS

Single-name peers

TickerNameSub-industry1Y3Y5Y10Y
CYTKCytokineticsBiotechnology0.380.270.330.27
SRPTSarepta TherapeuticsBiotechnology0.360.330.340.27
VIRVir Biotechnology, Inc.Biotechnology0.350.350.330.22
RCUSArcus Biosciences, Inc.Biotechnology0.340.340.390.30
FTREFortreaBiotechnology0.300.270.26
XNCRXencor IncBiotechnology0.290.340.390.34
NBIXNeurocrine BiosciencesBiotechnology0.270.240.290.29
UTHRUnited TherapeuticsBiotechnology0.270.230.230.21
TGTXTG Therapeutics, Inc.Biotechnology0.260.280.390.29
KRYSKrystal BiotechBiotechnology0.250.260.270.28
LGNDLigand Pharmaceuticals, Inc.Biotechnology0.250.280.350.32
ROIVRoivant SciencesBiotechnology0.240.320.28
VRTXVertex PharmaceuticalsBiotechnology0.220.250.280.26
PTGXProtagonist Therapeutics, Inc.Biotechnology0.180.190.230.14
BIIBBiogen Inc.Biotechnology0.170.300.330.23
BMRNBioMarin PharmaceuticalBiotechnology0.170.280.350.29
RGENRepligenBiotechnology0.170.320.360.30
GILDGilead SciencesBiotechnology0.160.190.240.19
EXELExelixisBiotechnology0.160.170.250.24
HALOHalozymeBiotechnology0.150.210.280.25
ALNYAlnylam PharmaceuticalsBiotechnology0.140.240.330.28
INCYIncyteBiotechnology0.140.240.290.26
AMGNAmgen Inc.Biotechnology0.140.230.220.23
HRMYHarmony Biosciences Holdings, Inc.Biotechnology0.130.200.29
ADMAADMA Biologics, Inc.Biotechnology0.130.170.290.22
MRNAModerna Inc.Biotechnology0.120.190.230.19
VCELVericelBiotechnology0.110.250.380.30
REGNRegeneron PharmaceuticalsBiotechnology0.110.240.260.22
ETFS

Fund stand-ins

An ETF is generally not 'substantially identical' to a single stock, which is why funds are the standard wash-sale-aware replacement.

TickerNameFocusMatch1Y3Y5Y10Y
XBISPDR S&P Biotech ETFBiotechnology (Equal Wt)INDUSTRY0.480.570.660.55
XPHSPDR S&P PharmaceuticalsPharmaceuticals (Equal Wt)INDUSTRY0.420.480.530.43
IBBiShares Biotechnology ETFBiotechnologyINDUSTRY0.420.530.600.49
ARKGARK Genomic Revolution ETFGenomics (Active)INDUSTRY0.350.470.550.48
IHEiShares US Pharmaceuticals ETFPharmaceuticalsINDUSTRY0.290.360.400.36
FHLCFidelity MSCI Health Care ETFHealth Care SectorSECTOR0.250.370.440.39
VHTVanguard Health Care ETFHealth Care SectorSECTOR0.250.370.440.39
IYHiShares US Healthcare ETFHealth Care SectorSECTOR0.230.340.410.36
PPHVanEck Pharma ETFPharmaceuticalsINDUSTRY0.210.290.340.31
XLVHealth Care Select Sector SPDRHealth Care SectorSECTOR0.190.310.370.33
IHFiShares Health Care ProvidersHealth Care ProvidersINDUSTRY0.130.170.270.30
IHIiShares Medical Devices ETFMedical DevicesSUB-IND0.090.250.370.36
NEXT STEPS

Harvesting a loss in ARWR?

RELATED

Replacement research for ARWR's peers

Browse all tickers →

Method: Pearson correlation of daily closing-price returns, Yahoo Finance data, series aligned by trading day, refreshed weekly. A cell is blank when overlapping history covers less than 60% of its window. Correlation is descriptive, not predictive. Wash-sale treatment depends on facts and circumstances — confirm with a tax professional. Not investment advice.